Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA
Marc J. Williams, Ignacio Vázquez-Garćıa, Grittney K. Tam…·Sohrab P. Shah
This study tracks clonal evolution of drug resistance in ovarian cancer using structural variants in cfDNA, finding polyclonal resistance with dominant high-fitness clones and genomic features linked to drug resistance.